Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis.

Carrillo-Aleman L, Marín F, Rivera-Caravaca JM, Vicente-Ibarra N, Candela-Sanchez E, Esteve-Pastor MA, Lozano T, Sandín-Rollan M, Pernias-Escrig V, Macías M, Quintana-Giner M, Veliz A, Orenes-Piñero E, Martínez-Martínez JG, Ruiz-Nodar JM.

Clin Drug Investig. 2019 Jan 8. doi: 10.1007/s40261-018-0736-z. [Epub ahead of print]

PMID:
30623372
2.

Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines.

Candela E, Marín F, Rivera-Caravaca JM, Vicente Ibarra N, Carrillo L, Esteve-Pastor MA, Lozano T, Macías MJ, Pernias V, Sandín M, Orenes-Piñero E, Quintana-Giner M, Hortelano I, Villamía B, Veliz A, Valdés M, Martínez-Martínez JG, Ruiz-Nodar JM.

PLoS One. 2018 Nov 28;13(11):e0208069. doi: 10.1371/journal.pone.0208069. eCollection 2018.

3.

Chronic Kidney Disease and Third-Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year.

Tello-Montoliu A, Ruiz-Nodar JM, Esteve-Pastor MA, Véliz-Martínez A, Orenes-Piñero E, Macías-Villanego MJ, Lozano T, Carrillo-Alemán L, Vicente-Ibarra N, Pernias-Escrig V, Martínez-Martínez JG, Rivera-Caravaca JM, Marín F.

J Clin Pharmacol. 2019 Feb;59(2):295-302. doi: 10.1002/jcph.1318. Epub 2018 Sep 12.

PMID:
30207603
4.

Familial Brugada Syndrome Associated With a Complete Deletion of the SCN5A and SCN10A Genes.

Trujillo-Quintero JP, Gutiérrez-Agulló M, Ochoa JP, Martínez-Martínez JG, de Uña D, García-Fernández A.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):176-178. doi: 10.1016/j.rec.2017.12.021. Epub 2018 Apr 9. English, Spanish. No abstract available.

PMID:
29650450
5.

Time-to-Effect-Based Dosing Strategy for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the plusONE Multicenter Randomized Controlled Noninferiority Trial.

Ferrero-de-Loma-Osorio Á, García-Fernández A, Castillo-Castillo J, Izquierdo-de-Francisco M, Ibáñez-Críado A, Moreno-Arribas J, Martínez A, Bertomeu-González V, López-Mases P, Ajo-Ferrer M, Núñez C, Bondanza-Saavedra L, Sánchez-Gómez JM, Martínez-Martínez JG, Chorro-Gascó FJ, Ruiz-Granell R.

Circ Arrhythm Electrophysiol. 2017 Dec;10(12). pii: e005318. doi: 10.1161/CIRCEP.117.005318.

PMID:
29247029
6.

The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.

García-Fernández A, Marín F, Roldán V, Galcerá-Jornet E, Martínez-Martínez JG, Valdés M, Sogorb F, Lip GY.

Int J Cardiol. 2016 Aug 15;217:42-8. doi: 10.1016/j.ijcard.2016.04.167. Epub 2016 May 3.

PMID:
27179207
7.

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion.

García-Fernández A, Marín F, Roldán V, Gómez-Sansano JM, Hernández-Romero D, Valdés M, Martinez-Martinez JG, Sogorb-Garri F, Lip GY.

Circ J. 2016;80(3):605-12. doi: 10.1253/circj.CJ-15-0992. Epub 2016 Jan 14.

8.

[Utility of verapamil in the treatment of diastolic dysfunction in patients with acromegaly].

Marín Ortuño F, Climent Payá VE, Picó Alfonso AM, Martínez Martínez JG, Sánchez Payá J, Sogorb Garri F.

Rev Clin Esp. 2003 Jan;203(1):15-9. Spanish.

PMID:
12605795
9.

[Should we try to determine the specific cause of cardiac tamponade?].

Oliver Navarrete C, Marín Ortuño F, Pineda Rocamora J, Luján Martínez J, García Fernández A, Climent Payá VE, Martínez Martínez JG, Aranda López I, Sogorb Garri F.

Rev Esp Cardiol. 2002 May;55(5):493-8. Spanish.

10.

[The efficacy of scheduled cardioversion in atrial fibrillation. Comparison of two schemes of treatment: electrical versus pharmacological cardioversion].

Valencia Martín J, Climent Payá VE, Marín Ortuño F, Monmeneu Menadas JV, Martínez Martínez JG, García Martínez M, Ibáñez Criado A, García De Burgos Rico F, Sogorb Garri F.

Rev Esp Cardiol. 2002 Feb;55(2):113-20. Spanish.

11.

[Thrombogenic and endothelial damage markers in patients with ischemic systolic impairment].

Roldán Schilling V, Marín Ortuño F, Pineda Rocamora J, Climent Payá VE, Martínez Martínez JG, Marco Vera P, de Teresa Parreño L, Sogorb Garri F.

Rev Esp Cardiol. 2001 Oct;54(10):1155-60. Spanish.

12.

[Biventricular impairment of diastolic function in acromegaly].

Marín Ortuño F, Picó Alfonso A AM, Martínez Martínez JG, Domínguez Escribano JR, Climent Payá VE, Pineda Rocamora J, Soborg Garri F.

Rev Esp Cardiol. 2001 Jan;54(1):37-42. Spanish.

13.

[Remission following verapamil use in acromegalic patient with heart failure].

Marín Ortuño F, Picó Alfonso AM, Martínez Martínez JG, Domínguez Escribano JR, Sogorb Garri F.

An Med Interna. 1999 Nov;16(11):607. Spanish. No abstract available.

PMID:
10638013
14.

[Natural-valve endocarditis in patients wearing pacemakers].

Climent Payá V, Martínez Martínez JG, Marín Ortuño F, Meseguer Oller J, Sogorb Garri F.

Rev Clin Esp. 1999 Jan;199(1):28-30. Review. Spanish.

PMID:
10089774
15.

[Improvement in fibrinolytic function following anticoagulant treatment in chronic rheumatic atrial fibrillation].

Marín Ortuño F, Roldán Schilling V, Marco Vera P, Martínez Martínez JG, Toral Noguera A, García de Burgos Rico F, Calatayud Sendra R, Sogorb Garri F.

Rev Esp Cardiol. 1999 Jan;52(1):25-30. Spanish.

16.

[Safety of oral anticoagulation in aged patients with heart diseases].

García Garay MC, Marín Ortuño F, Roldán Schilling V, Martínez Martínez JG, Marco Vera P, Sogorb Garri F.

Rev Clin Esp. 1998 May;198(5):294-6. Spanish.

PMID:
9658911
17.

[Dual-chamber pacemakers in obstructive hypertrophic cardiomyopathy: gradient variation with stress echocardiography].

Martínez Martínez JG, Ortuño Alcaraz D, Marín Ortuño F, Luján Martínez J, Ibáñez Criado A, Quiles Llorens JA, Sogorb Garri F.

Rev Esp Cardiol. 1998 Jan;51(1):51-5. Spanish.

Supplemental Content

Loading ...
Support Center